UROY Stock Analysis: Uranium Royalty | NASDAQ
Uranium | NASDAQ, USA | Market Cap: 388m USD | 12M Return: 17.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.11M
Qual. Beats: 3
Rev. Trend: 21.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 6.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Uranium Royalty Corp. (NASDAQ: UROY) is a Canada-based pure-play uranium royalty company with interests spanning Canada, the United States, Namibia, and Spain. Its business model centers on three activities: acquiring royalties on uranium projects, investing in uranium-exposed companies and physical uranium, and trading physical uranium directly. The company is headquartered in Vancouver and was incorporated in 2017, with its NASDAQ IPO completed in April 2021.
Unlike traditional mining operators, royalty companies do not typically develop, operate, or fund the extraction of the underlying commodity themselves. Instead, they provide upfront capital in exchange for a percentage of future production revenue or a share of revenue from a project, which generally results in lower operational risk and capital intensity compared to mining companies while still providing commodity price leverage. The global uranium market remains relatively concentrated, with a small number of producing countries - notably Kazakhstan, Canada, Namibia, and Australia - accounting for the majority of primary supply, and demand is closely tied to nuclear power generation.
- Uranium spot price rally lifts royalty income and trading margins
- Royalty portfolio expansion through new acquisitions diversifies revenue base
- AI and data center power demand drives nuclear utility procurement
| Net Income: 4.39m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 26.69 > 1.0 |
| NWC/Revenue: 592.8% < 20% (prev 1.03k%; Δ -436.9% < -1%) |
| CFO/TA 0.11 > 3% & CFO 41.0m > Net Income 4.39m |
| Net Debt (-138.9m) to EBITDA (5.26m): -26.40 < 3 |
| Current Ratio: 325.3 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.1m) vs 12m ago 8.47% < -2% |
| Gross Margin: 17.72% > 18% (prev 31.28%; Δ -13.56% > 0.5%) |
| Asset Turnover: 16.03% > 50% (prev 7.75%; Δ 8.28% > 0%) |
| Interest Coverage Ratio: 317.2 > 6 (EBIT TTM 5.08m / Interest Expense TTM 16.0k) |
| A: 0.85 (Total Current Assets 324.8m - Total Current Liabilities 999k) / Total Assets 383.0m |
| B: 0.06 (Retained Earnings 22.8m / Total Assets 383.0m) |
| C: 0.01 (EBIT TTM 5.08m / Avg Total Assets 340.8m) |
| D: 272.2 (Book Value of Equity 381.6m / Total Liabilities 1.40m) |
| Altman-Z'' = 291.6 = AAA |
| DSRI: 0.10 (Receivables 8.01k/596k, Revenue 54.6m/23.1m) |
| GMI: 1.76 (GM 31.28% / 17.72%) |
| AQI: 0.77 (AQ_t 0.15 / AQ_t-1 0.20) |
| SGI: 2.36 (Revenue 54.6m / 23.1m) |
| TATA: -0.10 (NI 4.39m - CFO 41.0m) / TA 383.0m) |
| Beneish M = -2.25 (Cap -4..+1) = BBB |
As of July 13, 2026, the stock is trading at USD 2.75 with a total of 1,860,533 shares traded. Over the past week, the price has changed by -2.14%, over one month by -1.43%, over three months by -23.18% and over the past year by +17.52%.
Current recommended Stop Loss: 2.50 (which is 9.1% or 1.5 ATR below the current price).
Uranium Royalty has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy UROY.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4.4 | 58.5% |
Market Cap CAD = 550.5m (388.5m USD * 1.417 USD.CAD)
P/E Trailing = 88.3333
P/E Forward = 13.7363
P/S = 7.1147
P/B = 1.4529
Revenue TTM = 54.6m CAD
EBIT TTM = 5.08m CAD
EBITDA TTM = 5.26m CAD
Long Term Debt = 50.2k CAD (estimated: total debt 168k - short term 118k)
Short Term Debt = 118k CAD (from shortTermDebt, last quarter)
Debt = 168k CAD (from shortLongTermDebtTotal, last quarter) (leases 168k already included)
Net Debt = -138.9m CAD (calculated: Debt 168k - CCE 139.1m)
Enterprise Value = 411.5m CAD (550.5m + Debt 168k - CCE 139.1m)
Interest Coverage Ratio = 317.2 (Ebit TTM 5.08m / Interest Expense TTM 16.0k)
EV/FCF = 10.31x (Enterprise Value 411.5m / FCF TTM 39.9m)
FCF Yield = 9.70% (FCF TTM 39.9m / Enterprise Value 411.5m)
FCF Margin = 73.07% (FCF TTM 39.9m / Revenue TTM 54.6m)
Net Margin = 8.03% (Net Income TTM 4.39m / Revenue TTM 54.6m)
Gross Margin = 17.72% ((Revenue TTM 54.6m - Cost of Revenue TTM 44.9m) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 29.27%)
Tobins Q-Ratio = 1.07 (Enterprise Value 411.5m / Total Assets 383.0m)
Interest Expense / Debt = 9.51% (Interest Expense 16.0k / Debt 168k)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 4.01m (EBIT 5.08m * (1 - 21.00%))
Current Ratio = 325.3 (out of range, set to none) (Total Current Assets 324.8m / Total Current Liabilities 999k)
Debt / Equity = 0.00 (Debt 168k / totalStockholderEquity, last quarter 381.6m)
Debt / EBITDA = -26.40 (Net Debt -138.9m / EBITDA 5.26m)
Debt / FCF = -3.48 (Net Debt -138.9m / FCF TTM 39.9m)
Total Stockholder Equity = 326.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 4.39m / Total Assets 383.0m)
RoE = 1.35% (Net Income TTM 4.39m / Total Stockholder Equity 326.0m)
RoCE = 1.56% (EBIT 5.08m / Capital Employed (Equity 326.0m + L.T.Debt 50.2k))
RoIC = 1.06% (NOPAT 4.01m / Invested Capital 379.4m)
WACC = 12.97% (E(550.5m)/V(550.6m) * Re(12.97%) + D(168k)/V(550.6m) * Rd(9.51%) * (1-Tc(0.21)))
Discount Rate = 12.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 12.11%
[DCF] Terminal Value 61.05% ; FCFF base≈39.9m ; Y1≈40.1m ; Y5≈42.5m
[DCF] Fair Price = 3.47 (EV 370.1m - Net Debt -138.9m = Equity 509.0m / Shares 146.6m; r=12.97% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.38 | # QB: 3
Revenue Correlation: 21.80 | Revenue CAGR: 12.67% | SUE: N/A | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.01 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2026-04-30): EPS=0.03 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+175.0% | GrowthRev=+87.7%
EPS next Year (2027-04-30): EPS=0.04 | Chg30d=N/A | Revisions=-25% | GrowthEPS=+33.3% | GrowthRev=+205.8%